2000
DOI: 10.1021/ci000066d
|View full text |Cite
|
Sign up to set email alerts
|

QSAR Models Using a Large Diverse Set of Estrogens

Abstract: Endocrine disruptors (EDs) have a variety of adverse effects in humans and animals. About 58,000 chemicals, most having little safety data, must be tested in a group of tiered assays. As assays will take years, it is important to develop rapid methods to help in priority setting. For application to large data sets, we have developed an integrated system that contains sequential four phases to predict the ability of chemicals to bind to the estrogen receptor (ER), a prevalent mechanism for estrogenic EDs. Here … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

3
234
0
1

Year Published

2001
2001
2021
2021

Publication Types

Select...
5
5

Relationship

1
9

Authors

Journals

citations
Cited by 332 publications
(243 citation statements)
references
References 40 publications
3
234
0
1
Order By: Relevance
“…Recent crystallographic structures of the human ER R subtype (hERR) with a number of ligands, including E 2 , DES, raloxifene, and 4-OH-tamoxifene, have also been reported (20,21). By aligning these four ligands on the basis of the superposition of their ER binding sites, we have been able to demonstrate the common binding characteristics among these ligands (22).…”
Section: Introductionmentioning
confidence: 86%
“…Recent crystallographic structures of the human ER R subtype (hERR) with a number of ligands, including E 2 , DES, raloxifene, and 4-OH-tamoxifene, have also been reported (20,21). By aligning these four ligands on the basis of the superposition of their ER binding sites, we have been able to demonstrate the common binding characteristics among these ligands (22).…”
Section: Introductionmentioning
confidence: 86%
“…For the external validation of the MLR and PLS models several parameters were calculated: Q 2 F1 [22] ,…”
Section: Model Validationmentioning
confidence: 99%
“…1,2) Quantitative structure-activity relationship (QSAR) studies on the structural features of estrogen receptor ligands show that an unhindered hydroxyl group on an aryl ring and a hydrophobic group attached para to the hydroxyl group are essential. [3][4][5][6] Ligand binding * To whom correspondence should be addressed: Nihon Pharmaceutical University, 10281 Komuro, Ina-machi, Kitaadachigun, Saitama 362-0806, Japan. Tel.…”
Section: Introductionmentioning
confidence: 99%